J. Goldman & CO LP Ionis Pharmaceuticals Inc Transaction History
J. Goldman & CO LP
- $3.8 Billion
- Q1 2025
A detailed history of J. Goldman & CO LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 307,770 shares of IONS stock, worth $13.2 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
307,770
Previous 607,499
49.34%
Holding current value
$13.2 Million
Previous $21.2 Million
56.28%
% of portfolio
0.24%
Previous 0.6%
Shares
5 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$705 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$696 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$532 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$444 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$362 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.1B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...